Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |